Form 6-K Acasti Pharma Inc. For: May 25
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Acasti Pharma (ACST) Reports Q1 Loss of $0.18
May 25, 2016 5:10 PM EDTAcasti Pharma (NASDAQ: ACST) reported Q1 EPS of ($0.18), versus ($0.21) reported last year. Revenue for the quarter came in at $21 thousand, versus $178 thousand reported last year.
For earnings history and earnings-related data on Acasti Pharma (ACST) click here.
... More